FCGR3A and neoplasm: Tumor-specific NK cells exhibits high expression of CD69 and NKp44 activation markers and low expression of NKp30, NKp80, DNAM-1, CD16, and ILT2 as compared to peripheral blood and normal lung NK cells (125).